Author:
Wang Shiyun,Zhang Rong,Hou Xuhong,Jiang Fusong,Wang Jie,He Zhen,Jiang Feng,Hu Cheng,Jia Weiping
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology
Reference33 articles.
1. Alberti, K.G.M.M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., and rskov, H. (1973). Inhibition of insulin secretion by somatostatin. Lancet 302, 1299–1301.
2. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77–79.
3. Christensen, S.E., Hansen, A.P., Orskov, H., and Lundbaek, K. (1978). Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics. Metabolism 27, 1427–1431.
4. De Martino, M.C., Hofland, L.J., and Lamberts, S.W. (2010). Somatostatin and somatostatin receptors: from basic concepts to clinical applications. Prog Brain Res 182, 255–280.
5. Efendic, S., Claro, A., and Laft, R. (1976). Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas. Acta Endocrinol (Copenh) 81, 753–761.